NCT06256718

Brief Summary

This study evaluates the implementation of evidence based strategies to optimize HPV vaccination in rural primary care settings. Some of the largest disparities in human papillomavirus vaccination (HPVV) rates exist in rural communities, which represent missed opportunities for cancer prevention. Primary care provider visits in these communities serve as a crucial opportunity to communicate the importance of timely vaccination that is essential to effective cancer prevention. This study implements and tests a practice-level intervention (PC TEACH) using practice facilitation of evidence-based strategies to expand reach to rural community-based primary care settings to optimize delivery and increase HPVV rates. PC TEACH program may help rural communities overcome access and awareness factors that keep them from receiving HPVV.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
203

participants targeted

Target at P75+ for not_applicable

Timeline
11mo left

Started May 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
May 2023Apr 2027

Study Start

First participant enrolled

May 24, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 2, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 13, 2024

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

3.9 years

First QC Date

February 2, 2024

Last Update Submit

March 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Adolescent HPV vaccination rates

    To evaluate the impact (short and long-term) of the proposed PC TEACH (primary care practice-level, medical office-based intervention) intervention on human papilloma virus vaccine (HPVV) uptake and completion rates using a staggered (stepped-wedge) intervention schedule. Briefly, practice-specific vaccine rates data will be modeled as a function of time in intervention (0, 6, 12, 18, or 24 months), while adjusting for baseline rates collected prior to intervention for each practice. For vaccine rates, an additional factor for calendar time will be included in the model to address potential seasonal effects.

    Up to 5 years (60 months)

Secondary Outcomes (1)

  • Age at vaccination

    Up to 5 years (60 months)

Study Arms (1)

Health services research (PC TEACH)

OTHER

Primary practice providers sites receive PC TEACH over 3.5 hours for 12 months

Other: Educational Intervention

Interventions

Evidence-based strategy (PC TEACH)

Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Health services research (PC TEACH)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PRACTICES: Are located in the 20-county target region
  • PRACTICES: Have an adolescent patient population \>= 150 (aged 9-18)
  • PRACTICES: Administer adolescent vaccines (e.g., HPV, Tdap, MCV4)
  • PRACTICES: Are willing to share aggregate practice and patient-level data (e.g., electronic health record \[EHR\], surveys)
  • PARTICIPANTS: Medical providers and medical staff \>= 18 years of age
  • PARTICIPANTS: Primary care providers and medical office staff who deliver adolescent care at community-based primary care practice sites across 20 rural counties in central and western New York
  • PARTICIPANTS: Age \>= 18 years of age (no upper limit)
  • PARTICIPANTS: English speaking
  • PARENT/GUARDIAN SURVEY: Adult accompanying a child or children aged 9 to 17
  • PARENT/GUARDIAN SURVEY: English speaking
  • PARENT/GUARDIAN SURVEY: Presenting to the participating clinic for an outpatient well child visit or regular checkup
  • PARENT/GUARDIAN SURVEY: Willing to complete an anonymous survey while visiting the clinic

You may not qualify if:

  • Unwilling or unable to follow protocol requirements
  • Adults unable to complete study measures in English
  • Individuals who are not yet adults (infants, children, teenagers)
  • Cognitively impaired adults/adults with impaired decision-making capacity
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Roswell Park Cancer Institute

Buffalo, New York, 14263, United States

Location

MeSH Terms

Conditions

Papillomavirus Infections

Interventions

Early Intervention, EducationalEducational StatusMethods

Condition Hierarchy (Ancestors)

Sexually Transmitted Diseases, ViralSexually Transmitted DiseasesCommunicable DiseasesInfectionsDNA Virus InfectionsVirus DiseasesTumor Virus InfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health ServicesSocioeconomic FactorsPopulation CharacteristicsInvestigative Techniques

Study Officials

  • Elisa Rodriguez

    Roswell Park Cancer Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2024

First Posted

February 13, 2024

Study Start

May 24, 2023

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

April 30, 2027

Last Updated

March 17, 2026

Record last verified: 2026-03

Locations